Real-world insights into non-small cell lung cancer patients with MET exon 14 skipping mutations: A Swedish retrospective study from two university hospitals

被引：0
|
作者：
Skribek, M. [1 ]
Brunnstrom, H. [2 ]
Aricak, O. [3 ]
Planck, M. [4 ]
Jatta, K. [5 ]
Oskarsdottir, G. N. [4 ]
Naserhojati, H. [6 ]
Haglund, F. [7 ]
Ekman, S. [8 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Lund Univ, Div Pathol, Lund, Sweden
[3] Karolinska Univ Hosp, Dept Pathol & Cytol, Solna, Sweden
[4] Lund Univ, Div Oncol, Lund, Sweden
[5] Karolinska Univ Hosp Solna, Dept Pathol & Cytol, Solna, Sweden
[6] Karolinska Univ Hosp, Dept Pathol & Cytol, Huddinge, Sweden
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Karolinska Inst, Dept Oncol Pathol, Solna, Sweden
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1302
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1179P
引用
收藏
页码：S1087 / S1087
页数：1
相关论文
共 50 条
  • [1] Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals
    Skribek, Marcus
    Brunnstrom, Hans
    Oskarsdottir, Gudrun
    Grive, Mikel Portu
    Aricak, Ozan
    Planck, Maria
    Jatta, Kenbugul
    Naserhojati, Homeyra
    de Flon, Felix Haglund
    Ekman, Simon
    ACTA ONCOLOGICA, 2023, 62 (12) : 1808 - 1814
  • [2] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Huang, Caiwen
    Zou, Qihua
    Liu, Hui
    Qiu, Bo
    Li, Qiwen
    Lin, Yongbin
    Liang, Ying
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [3] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Caiwen Huang
    Qihua Zou
    Hui Liu
    Bo Qiu
    Qiwen Li
    Yongbin Lin
    Ying Liang
    Current Treatment Options in Oncology, 2020, 21
  • [4] Real-world experience in treatment of patients with non-small cell lung cancer with BRAF and cMET Exon 14 skipping mutations
    Janzic, U.
    Shalata, W.
    Agbarya, A.
    Dziadziuszko, R.
    Szymczak, K.
    Jakopovic, M.
    Mountzios, G.
    Pluzanski, A.
    ANNALS OF ONCOLOGY, 2023, 34
  • [5] The characteristics of MET exon 14 skipping mutations in Chinese non-small cell lung cancer: A retrospective analysis
    Zhu, Y.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 5 - 5
  • [6] Retrospective Analysis to Optimize the Detection of MET Exon 14 Skipping Mutations in Non-Small Cell Lung Cancer
    Lu, Jang-Jih
    Tsai, Shu-Hui
    Lin, Lee-Chung
    Chiueh, Tzong-Shi
    DIAGNOSTICS, 2024, 14 (11)
  • [7] MET Exon 14 Skipping in Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    Shim, Hyo Sup
    Gingipally, Shalini
    Mino-Kenudson, Mari
    Le, Long
    Gainor, Justin F.
    Zheng, Zongli
    Aryee, Martin
    Xia, Junfeng
    Jia, Peilin
    Jin, Hailing
    Zhao, Zhongming
    Pao, Gwilliam
    Engelman, Jeffrey A.
    Iafrate, A. John
    ONCOLOGIST, 2016, 21 (04): : 481 - 486
  • [8] MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
    Jorgensen, Jan Trost
    Urbanska, Edyta M.
    Mollerup, Jens
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 940 - 946
  • [9] Comprehensive characterization of MET exon 14 skipping mutations in non-small cell lung cancer
    Wu, Xue
    Zhang, Yaru
    Pang, Jiaohui
    Lin, Li
    Yin, Jiani C.
    Tang, Haimeng
    Shao, Yang
    CANCER RESEARCH, 2023, 83 (07)
  • [10] A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
    Santarpia, Mariacarmela
    Massafra, Marco
    Gebbia, Vittorio
    D'Aquino, Antonio
    Garipoli, Claudia
    Altavilla, Giuseppe
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1536 - +
12345